Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Angiosarcoma”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Study completedNCT03544567
What this trial is testing

Oraxol in Subjects With Cutaneous Angiosarcoma

Who this might be right for
Angiosarcoma of Skin
Athenex, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT07007273
What this trial is testing

Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma

Who this might be right for
Cutaneous Sarcoma
H. Lee Moffitt Cancer Center and Research Institute 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03921008
What this trial is testing

Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

Who this might be right for
Cutaneous Angiosarcoma
Washington University School of Medicine 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04339738
What this trial is testing

Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma

Who this might be right for
Skin AngiosarcomaSkin Radiation-Related AngiosarcomaVisceral Angiosarcoma
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Looking for participantsNCT06673628
What this trial is testing

Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients

Who this might be right for
Angiosarcoma of SkinAngiosarcoma Metastatic
National Cancer Center, Japan 38
Testing effectiveness (Phase 2)Study completedNCT04518124
What this trial is testing

Propranolol in Angiosarcoma

Who this might be right for
Angiosarcoma
The Netherlands Cancer Institute 14
Early research (Phase 1)WithdrawnNCT05799612
What this trial is testing

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

Who this might be right for
Angiosarcoma
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Not applicableEnded earlyNCT05729425
What this trial is testing

Evaluating the Accuracy of Microvessel Ultrasound Imaging for Detecting Extent of Disease in Patients With Angiosarcoma of the Skin

Who this might be right for
Skin Angiosarcoma
Mayo Clinic 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT03069378
What this trial is testing

Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Who this might be right for
SarcomaEpithelioid SarcomaCutaneous Angiosarcoma
Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Ended earlyNCT03921073
What this trial is testing

Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma

Who this might be right for
Angiosarcoma of Skin
H. Lee Moffitt Cancer Center and Research Institute 5